PubRank

Lee H Harrison

Author PubWeight™ 301.55‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007 26.98
2 Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003 15.48
3 Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005 12.75
4 Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010 8.37
5 Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 2006 7.68
6 Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 2007 6.45
7 Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008 6.13
8 The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis 2007 5.36
9 Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 2005 5.29
10 A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 2005 5.26
11 Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis 2008 4.91
12 A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002 4.88
13 Health care-associated invasive MRSA infections, 2005-2008. JAMA 2010 4.79
14 Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol 2004 4.51
15 Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med 2009 4.38
16 National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med 2013 4.21
17 Automatic electronic laboratory-based reporting of notifiable infectious diseases at a large health system. Emerg Infect Dis 2002 3.88
18 Behavioral impact, acceptability, and HIV incidence among homosexual men with access to postexposure chemoprophylaxis for HIV. J Acquir Immune Defic Syndr 2004 3.86
19 Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease. Clin Infect Dis 2010 3.61
20 Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nat Med 2003 3.54
21 Multilocus sequence typing as a replacement for serotyping in Salmonella enterica. PLoS Pathog 2012 3.37
22 Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. JAMA 2004 3.05
23 Bacterial meningitis in the United States, 1998-2007. N Engl J Med 2011 2.99
24 Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA 2006 2.93
25 Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach. Clin Infect Dis 2007 2.90
26 Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration. J Acquir Immune Defic Syndr 2007 2.71
27 Multilocus variable-number tandem repeat analysis distinguishes outbreak and sporadic Escherichia coli O157:H7 isolates. J Clin Microbiol 2003 2.69
28 Clonal distribution of invasive pneumococcal isolates from children and selected adults in the United States prior to 7-valent conjugate vaccine introduction. J Clin Microbiol 2003 2.59
29 Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. Clin Infect Dis 2009 2.56
30 Multilocus variable-number tandem-repeat analysis for investigation of Clostridium difficile transmission in Hospitals. J Clin Microbiol 2006 2.52
31 tcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile. J Clin Microbiol 2006 2.49
32 Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002. J Clin Microbiol 2006 2.46
33 Risk factors for severe respiratory syncytial virus infection among Alaska native children. Pediatrics 2002 2.46
34 High incidence and prevalence of HIV-1 infection in high risk population in Calcutta, India. Int J STD AIDS 2003 2.41
35 Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy. Clin Infect Dis 2002 2.30
36 Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med 2009 2.25
37 Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors. Emerg Infect Dis 2006 2.25
38 Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: A 60-year follow-up study. JAMA 2004 2.25
39 Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates. Antimicrob Agents Chemother 2002 2.20
40 Multilocus sequence typing reveals a lack of diversity among Escherichia coli O157:H7 isolates that are distinct by pulsed-field gel electrophoresis. J Clin Microbiol 2003 2.16
41 Characterization of methicillin-resistant Staphylococcus aureus isolates collected in 2005 and 2006 from patients with invasive disease: a population-based analysis. J Clin Microbiol 2009 2.06
42 The changing and dynamic epidemiology of meningococcal disease. Vaccine 2011 2.05
43 Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania. Antimicrob Agents Chemother 2008 2.03
44 Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance. Infect Control Hosp Epidemiol 2005 2.00
45 Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011. Clin Infect Dis 2012 1.91
46 FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from U.S. population-based surveillance. Antimicrob Agents Chemother 2010 1.79
47 Predictors of virologic failure in HIV-1-infected patients starting highly active antiretroviral therapy in Porto Alegre, Brazil. J Acquir Immune Defic Syndr 2005 1.69
48 Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995-2000. J Infect Dis 2005 1.68
49 Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011. J Clin Microbiol 2012 1.68
50 Changes in invasive Pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization. Ann Intern Med 2006 1.67
51 Multistate surveillance for laboratory-confirmed, influenza-associated hospitalizations in children: 2003-2004. Pediatr Infect Dis J 2006 1.59
52 Validation of a hierarchical deterministic record-linkage algorithm using data from 2 different cohorts of human immunodeficiency virus-infected persons and mortality databases in Brazil. Am J Epidemiol 2008 1.58
53 Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission. Clin Infect Dis 2013 1.58
54 Increase in non-AIDS related conditions as causes of death among HIV-infected individuals in the HAART era in Brazil. PLoS One 2008 1.56
55 Invasive group A streptococcal disease: risk factors for adults. Emerg Infect Dis 2003 1.48
56 Racial disparities in invasive Streptococcus pneumoniae infections, 1998-2009. Clin Infect Dis 2014 1.47
57 Multi-locus variable number tandem repeat analysis for investigation of the genetic association of Clostridium difficile isolates from food, food animals and humans. Anaerobe 2011 1.45
58 sodC-based real-time PCR for detection of Neisseria meningitidis. PLoS One 2011 1.45
59 Temporal changes in causes of death among HIV-infected patients in the HAART era in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr 2009 1.45
60 Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines. J Infect Dis 2011 1.42
61 Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates. Vaccine 2009 1.42
62 Creating a text classifier to detect radiology reports describing mediastinal findings associated with inhalational anthrax and other disorders. J Am Med Inform Assoc 2003 1.42
63 Integron-mediated multidrug resistance in a global collection of nontyphoidal Salmonella enterica isolates. Emerg Infect Dis 2009 1.41
64 High frequency of rifampin resistance identified in an epidemic Clostridium difficile clone from a large teaching hospital. Clin Infect Dis 2009 1.41
65 Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States. Vaccine 2011 1.40
66 Locus-specific mutational events in a multilocus variable-number tandem repeat analysis of Escherichia coli O157:H7. J Clin Microbiol 2006 1.38
67 Emergence of a novel penicillin-nonsusceptible, invasive serotype 35B clone of Streptococcus pneumoniae within the United States. J Infect Dis 2002 1.38
68 Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome. Antimicrob Agents Chemother 2006 1.37
69 Socioeconomic and racial/ethnic disparities in the incidence of bacteremic pneumonia among US adults. Am J Public Health 2010 1.33
70 Phenotypic and molecular characterization of serogroup C Neisseria meningitidis associated with an outbreak in Bahia, Brazil. Enferm Infecc Microbiol Clin 2011 1.32
71 Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization. AIDS 2010 1.32
72 Current epidemiology and trends in invasive Haemophilus influenzae disease--United States, 1989-2008. Clin Infect Dis 2011 1.30
73 Incorporation of real-time PCR into routine public health surveillance of culture negative bacterial meningitis in São Paulo, Brazil. PLoS One 2011 1.28
74 Association of relapse of Clostridium difficile disease with BI/NAP1/027. J Clin Microbiol 2012 1.27
75 Epidemiology of invasive pneumococcal disease among high-risk adults since the introduction of pneumococcal conjugate vaccine for children. Clin Infect Dis 2012 1.26
76 Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settings. J Acquir Immune Defic Syndr 2010 1.25
77 Trends in invasive methicillin-resistant Staphylococcus aureus infections. Pediatrics 2013 1.23
78 Multilocus variable-number tandem-repeat analysis and multilocus sequence typing reveal genetic relationships among Clostridium difficile isolates genotyped by restriction endonuclease analysis. J Clin Microbiol 2009 1.21
79 Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis. Pediatr Infect Dis J 2008 1.19
80 Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States. Clin Infect Dis 2011 1.15
81 Risk factors for pediatric invasive group A streptococcal disease. Emerg Infect Dis 2005 1.15
82 Correlating epidemiologic trends with the genotypes causing meningococcal disease, Maryland. Emerg Infect Dis 2004 1.14
83 Recurrent invasive pneumococcal disease in individuals with human immunodeficiency virus infection. J Infect Dis 2002 1.11
84 Universal methicillin-resistant Staphylococcus aureus (MRSA) surveillance for adults at hospital admission: an economic model and analysis. Infect Control Hosp Epidemiol 2010 1.09
85 Stability of allelic frequencies and distributions of Candida albicans microsatellite loci from U.S. population-based surveillance isolates. J Clin Microbiol 2003 1.09
86 Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccine. J Infect Dis 2007 1.08
87 Whole genome sequencing to investigate the emergence of clonal complex 23 Neisseria meningitidis serogroup Y disease in the United States. PLoS One 2012 1.07
88 Evaluating the potential public health impact of a Staphylococcus aureus vaccine through use of population-based surveillance for invasive methicillin-resistant S. aureus disease in the United States. Vaccine 2009 1.06
89 Perirectal swab surveillance for Clostridium difficile by use of selective broth preamplification and real-time PCR detection of tcdB. J Clin Microbiol 2011 1.05
90 Invasive methicillin-resistant Staphylococcus aureus infections among patients on chronic dialysis in the United States, 2005-2011. Clin Infect Dis 2013 1.02
91 Screening for Acinetobacter baumannii colonization by use of sponges. J Clin Microbiol 2010 1.01
92 Effectiveness of antiretroviral therapy among patients who attend public HIV clinics in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr 2004 1.01
93 Adherence to antiretroviral therapy and persistence of HIV RNA in semen. J Acquir Immune Defic Syndr 2003 1.00
94 Phenotypic and molecular characterization of invasive serogroup W135 Neisseria meningitidis strains from 1990 to 2005 in Brazil. J Infect 2010 0.98
95 Determining risk factors for candidemia among newborn infants from population-based surveillance: Baltimore, Maryland, 1998-2000. Pediatr Infect Dis J 2005 0.97
96 Deletion of fetA gene sequences in serogroup B and C Neisseria meningitidis isolates. J Clin Microbiol 2007 0.97
97 Excess costs of hospital care associated with neonatal candidemia. Pediatr Infect Dis J 2007 0.97
98 Meningococcal vaccines: current issues and future strategies. Drugs 2013 0.97
99 Economic impact of Acinetobacter baumannii infection in the intensive care unit. Infect Control Hosp Epidemiol 2010 0.95
100 Effect of Culture-Independent Diagnostic Tests on Future Emerging Infections Program Surveillance. Emerg Infect Dis 2015 0.95
101 Capsular switching in invasive Neisseria meningitidis, Brazil(1). Emerg Infect Dis 2012 0.94
102 Epidemiology of community-onset candidemia in Connecticut and Maryland. Clin Infect Dis 2006 0.93
103 Use of surveillance data to estimate the effectiveness of the 7-valent conjugate pneumococcal vaccine in children less than 5 years of age over a 9 year period. Vaccine 2012 0.92
104 The economic effect of screening orthopedic surgery patients preoperatively for methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2010 0.91
105 Prevalence of Clostridium difficile in uncooked ground meat products from Pittsburgh, Pennsylvania. Appl Environ Microbiol 2012 0.90
106 Effect of the 2009 influenza A(H1N1) pandemic on invasive pneumococcal pneumonia. J Infect Dis 2013 0.90
107 An assessment of the screening method to evaluate vaccine effectiveness: the case of 7-valent pneumococcal conjugate vaccine in the United States. PLoS One 2012 0.89
108 Genotyping primers for fully automated multilocus variable-number tandem repeat analysis of Escherichia coli O157:H7. J Clin Microbiol 2004 0.89
109 Estimating the extent of underreporting of mortality among HIV-infected individuals in Rio de Janeiro, Brazil. AIDS Res Hum Retroviruses 2010 0.89
110 Association between antimicrobial resistance among pneumococcal isolates and burden of invasive pneumococcal disease in the community. Clin Infect Dis 2002 0.89
111 Early-onset group B streptococcal disease in the United States: potential for further reduction. Obstet Gynecol 2014 0.88
112 Patient-associated risk factors for acquisition of methicillin-resistant Staphylococcus aureus in a tertiary care hospital. Infect Control Hosp Epidemiol 2010 0.87
113 Geographic, demographic, and seasonal differences in penicillin-resistant Streptococcus pneumoniae in Baltimore. Clin Infect Dis 2001 0.86
114 Preclinical evidence for the potential of a bivalent fHBP vaccine to prevent Neisseria meningitidis Serogroup C Disease. Hum Vaccin 2011 0.86
115 Should vascular surgery patients be screened preoperatively for methicillin-resistant Staphylococcus aureus? Infect Control Hosp Epidemiol 2009 0.86
116 Diversity of factor H-binding protein in Neisseria meningitidis carriage isolates. Vaccine 2011 0.85
117 Molecular epidemiology of Neisseria meningitidis serogroup B in Brazil. PLoS One 2012 0.85
118 Erythromycin-nonsusceptible Streptococcus pneumoniae in children, 1999-2001. Emerg Infect Dis 2005 0.85
119 β-Lactam resistance, serotype distribution, and genotypes of meningitis-causing Streptococcus pneumoniae, Rio de Janeiro, Brazil. Pediatr Infect Dis J 2012 0.84
120 Identification of a high-risk heterosexual cohort for HIV vaccine efficacy trials in Rio de Janeiro, Brazil, using a sensitive/less-sensitive assay: an update. J Acquir Immune Defic Syndr 2004 0.84
121 Invasive Haemophilus influenzae in the United States, 1999-2008: epidemiology and outcomes. J Infect 2012 0.84
122 Invasive group A streptococcal infection in older adults in long-term care facilities and the community, United States, 1998-2003. Emerg Infect Dis 2007 0.84
123 Neisseria meningitidis ST-11 clonal complex bearing capsule serogroups B, C, or W in Brazil. J Infect 2013 0.83
124 Serotype 14 variants of the France 9V(-3) clone from Baltimore, Maryland, can be differentiated by the cpsB gene. J Clin Microbiol 2004 0.83
125 Immunogenicity and safety of meningococcal C conjugate vaccine in children and adolescents infected and uninfected with HIV in Rio de Janeiro, Brazil. Pediatr Infect Dis J 2015 0.83
126 Escherichia coli producing CMY-2 β-lactamase in retail chicken, Pittsburgh, Pennsylvania, USA. Emerg Infect Dis 2012 0.83
127 Internet death notices as a novel source of mortality surveillance data. Am J Epidemiol 2007 0.82
128 Asymptomatic Clostridium difficile colonization as a reservoir for Clostridium difficile infection. Expert Rev Anti Infect Ther 2014 0.82
129 High prevalence of sexually transmitted diseases in young women seeking HIV testing in Rio de Janeiro, Brazil. Sex Transm Dis 2004 0.81
130 Fast test for assessing the susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin by real-time PCR. Mem Inst Oswaldo Cruz 2012 0.81
131 Twenty Years of Active Bacterial Core Surveillance. Emerg Infect Dis 2015 0.81
132 Training in Infectious Disease Epidemiology through the Emerging Infections Program Sites. Emerg Infect Dis 2015 0.79
133 Natural history of multidrug-resistant Acinetobacter baumannii carriage in intensive care units. Infect Control Hosp Epidemiol 2012 0.79
134 Vaccine prevention of meningococcal disease: making slow progress. Clin Infect Dis 2006 0.79
135 A multivalent conjugate vaccine for prevention of meningococcal disease in infants. JAMA 2008 0.79
136 Emerging Infections Program--State Health Department Perspective. Emerg Infect Dis 2015 0.77
137 Molecular epidemiological investigation to determine the source of a fatal case of serotype 22F pneumococcal meningitis. J Med Microbiol 2012 0.75
138 Use of sodC versus ctrA for real-time polymerase chain reaction-based detection of Neisseria meningitidis in sterile body fluids. Mem Inst Oswaldo Cruz 2013 0.75
139 College and university compliance with a required meningococcal vaccination law. J Am Coll Health 2007 0.75
140 Invasive Neisseria meningitidis strain expressing capsular polysaccharides W and Y in Brazil. J Clin Microbiol 2012 0.75
141 Three outbreak-causing Neisseria meningitidis serogroup C clones, Brazil(1.). Emerg Infect Dis 2013 0.75
142 Use of Vaccinia Virus Smallpox Vaccine in Laboratory and Health Care Personnel at Risk for Occupational Exposure to Orthopoxviruses - Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015. MMWR Morb Mortal Wkly Rep 2016 0.75
143 Distribution of penicillin-nonsusceptible pneumococcal clones in the Baltimore metropolitan area and variables associated with drug resistance. Clin Infect Dis 2002 0.75